CAMX:STO
Camurus AB
SEK ७२९.५०
arrow_downward
-१.४२%(-१०.५०) 1D
नोभेम्बर १७, १७:२९:४४ GMT+१ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
SEK ७३६.००
High
SEK ७३९.००
Low
SEK ७२४.५०
Mkt. cap
४४.८१ अरब
Avg. vol.
१.०७ लाख
Volume
८५.१६ हजार
52-wk high
SEK ७५०.००
52-wk low
SEK ४३०.८०
Shares outstanding
६.०६ करोड
No. of employees
३२३
Open
SEK ७३६.००
High
SEK ७३९.००
Low
SEK ७२४.५०
Mkt. cap
४४.८१ अरब
Avg. vol.
१.०७ लाख
Volume
८५.१६ हजार
52-wk high
SEK ७५०.००
52-wk low
SEK ४३०.८०
Shares outstanding
६.०६ करोड
No. of employees
३२३
News stories
From web sources and news partners
Fox Business
·
५९ मिनेट पहिले
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
MarketWatch
·
३३ मिनेट पहिले
The S&P 500 is testing a key technical floor. Is it time to buy, or brace for a bear market?
MarketWatch
·
३० मिनेट पहिले
Only two ‘Magnificent Seven’ stocks have managed to beat the S&P 500 since the start of 2025
Traders Union
·
१ घण्टा पहिले
Bitcoin-to-S&P 500 ratio holds trendline support, James Van Straten notes
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB